JP2020537514A - バイオマーカー - Google Patents

バイオマーカー Download PDF

Info

Publication number
JP2020537514A
JP2020537514A JP2020518706A JP2020518706A JP2020537514A JP 2020537514 A JP2020537514 A JP 2020537514A JP 2020518706 A JP2020518706 A JP 2020518706A JP 2020518706 A JP2020518706 A JP 2020518706A JP 2020537514 A JP2020537514 A JP 2020537514A
Authority
JP
Japan
Prior art keywords
chromosomal
interactions
nucleic acids
probe
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020518706A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020537514A5 (enExample
JPWO2019069067A5 (enExample
Inventor
アクーリチェフ、アレクサンドル
ラマダス、アロウル、セルヴァム
ハンター、ユアン
ソルター、マシュー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biodynamics PLC
Original Assignee
Oxford Biodynamics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biodynamics PLC filed Critical Oxford Biodynamics PLC
Publication of JP2020537514A publication Critical patent/JP2020537514A/ja
Publication of JP2020537514A5 publication Critical patent/JP2020537514A5/ja
Publication of JPWO2019069067A5 publication Critical patent/JPWO2019069067A5/ja
Priority to JP2023145557A priority Critical patent/JP7701419B2/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2020518706A 2017-10-02 2018-10-01 バイオマーカー Pending JP2020537514A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023145557A JP7701419B2 (ja) 2017-10-02 2023-09-07 バイオマーカー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762566756P 2017-10-02 2017-10-02
US62/566,756 2017-10-02
PCT/GB2018/052808 WO2019069067A1 (en) 2017-10-02 2018-10-01 BIOMARKER

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023145557A Division JP7701419B2 (ja) 2017-10-02 2023-09-07 バイオマーカー

Publications (3)

Publication Number Publication Date
JP2020537514A true JP2020537514A (ja) 2020-12-24
JP2020537514A5 JP2020537514A5 (enExample) 2021-11-11
JPWO2019069067A5 JPWO2019069067A5 (enExample) 2023-02-02

Family

ID=63834322

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020518706A Pending JP2020537514A (ja) 2017-10-02 2018-10-01 バイオマーカー
JP2023145557A Active JP7701419B2 (ja) 2017-10-02 2023-09-07 バイオマーカー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023145557A Active JP7701419B2 (ja) 2017-10-02 2023-09-07 バイオマーカー

Country Status (11)

Country Link
US (1) US12006547B2 (enExample)
EP (1) EP3692168A1 (enExample)
JP (2) JP2020537514A (enExample)
KR (1) KR102762920B1 (enExample)
CN (1) CN111344415B (enExample)
AU (1) AU2018344573B2 (enExample)
CA (1) CA3076450A1 (enExample)
MY (1) MY200184A (enExample)
SG (1) SG11202002503TA (enExample)
WO (1) WO2019069067A1 (enExample)
ZA (1) ZA202001821B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3152645A1 (en) * 2019-09-11 2021-03-18 Oxford BioDynamics PLC Diagnostic chromosome marker
GB202016176D0 (en) * 2020-10-12 2020-11-25 Oxford BioDynamics PLC Disease marker
EP4274910A1 (en) * 2021-01-07 2023-11-15 Oxford BioDynamics PLC Chromosome interactions
CN113035298B (zh) * 2021-04-02 2023-06-20 南京信息工程大学 递归生成大阶数行限制覆盖阵列的药物临床试验设计方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0767661A (ja) * 1993-03-05 1995-03-14 General Hospital Corp:The ハンチンチンｄｎａ、そのタンパク質及びその用途
JP2009500031A (ja) * 2005-07-04 2009-01-08 エラスムス ユニバーシティ メディカル センター 染色体コンフォメーションキャプチャ−オン−チップ（４ｃ）アッセイ
JP2011092137A (ja) * 2009-10-30 2011-05-12 Sysmex Corp 疾患の罹患の判定方法
JP2011521633A (ja) * 2008-06-02 2011-07-28 オックスフォード バイオダイナミックス リミテッド 長距離染色体相互作用を検出する方法
US20120302449A1 (en) * 2011-05-18 2012-11-29 Life Technologies Corporation Chromosome Conformation Analysis
WO2016207653A1 (en) * 2015-06-24 2016-12-29 Oxford Biodynamics Limited Detection of chromosome interactions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017001568A1 (en) * 2015-07-01 2017-01-05 Universitat De Lleida Treatment and prevention of amyotrophic lateral sclerosis
MY191260A (en) 2016-12-23 2022-06-12 Oxford BioDynamics PLC Typing method

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0767661A (ja) * 1993-03-05 1995-03-14 General Hospital Corp:The ハンチンチンｄｎａ、そのタンパク質及びその用途
JP2009500031A (ja) * 2005-07-04 2009-01-08 エラスムス ユニバーシティ メディカル センター 染色体コンフォメーションキャプチャ−オン−チップ（４ｃ）アッセイ
JP2011521633A (ja) * 2008-06-02 2011-07-28 オックスフォード バイオダイナミックス リミテッド 長距離染色体相互作用を検出する方法
JP2011092137A (ja) * 2009-10-30 2011-05-12 Sysmex Corp 疾患の罹患の判定方法
US20120302449A1 (en) * 2011-05-18 2012-11-29 Life Technologies Corporation Chromosome Conformation Analysis
WO2016207653A1 (en) * 2015-06-24 2016-12-29 Oxford Biodynamics Limited Detection of chromosome interactions
WO2016207647A1 (en) * 2015-06-24 2016-12-29 Oxford Biodynamics Limited Epigenetic chromosome interactions

Also Published As

Publication number Publication date
KR102762920B1 (ko) 2025-02-04
WO2019069067A1 (en) 2019-04-11
AU2018344573B2 (en) 2020-09-17
KR20200058527A (ko) 2020-05-27
SG11202002503TA (en) 2020-04-29
ZA202001821B (en) 2022-10-26
AU2018344573A1 (en) 2020-04-09
MY200184A (en) 2023-12-12
NZ762713A (en) 2025-03-28
JP2023182591A (ja) 2023-12-26
US12006547B2 (en) 2024-06-11
JP7701419B2 (ja) 2025-07-01
CN111344415A (zh) 2020-06-26
US20200407790A1 (en) 2020-12-31
CA3076450A1 (en) 2019-04-11
EP3692168A1 (en) 2020-08-12
CN111344415B (zh) 2024-04-30

Similar Documents

Publication Publication Date Title
JP7297015B2 (ja) エピジェネティックな染色体相互作用
JP7701419B2 (ja) バイオマーカー
JP7631400B2 (ja) 遺伝子調節
US20230143011A1 (en) METHODS OF DETECTING circRNA
JP2025032205A (ja) 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー
JP2025108590A (ja) 診断用染色体マーカー
US11535893B2 (en) Typing method
JPWO2019069067A5 (enExample)
KR20230019939A (ko) 섬유증, 예를 들어 경피증에 대한 마커로서의 염색체 형태 검출
JP2023545364A (ja) 疾患マーカー
HK40031541B (zh) 生物标志物
HK40031541A (en) Biomarker
JP2022512842A (ja) 染色体バイオマーカー

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210930

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210930

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220713

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220726

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221025

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221223

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20230125

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230509